Hemp Stocks

    Du lässt dich auf Dealer-Geschäfte ein

    Wer hier investiert, trägt ein hohes, da nicht kalkulierbares, Risiko, dass die Trump-Administration den Anbau und Handel verbietet.


    Ich stell deine Berechnungen nicht in Zweifel: Drogenhandel war und ist immer rentabel, solange man nicht daran gehindert wird, sei es durch die Justiz oder die Politik. Und das hat seinen Preis, bzw wird an der Börse abdiskontiert.


    Da ist mir meine Plantage zu Hause versteckt in einer Waldlichtung lieber. Die Kosten sind extrem niedrig, das Risiko gleich Null, denn ich verkaufe dem Interessenten die Ware zum selber ernten. Er gibt mir die Kohle, ich sage ihm den Ort, und er erntet auf eigenes Risiko!


    Ist nur Spass! Aber so würde ich es machen. Aufzucht ist spott billig, Zeit habe ich auch, und das Risiko besteht einzig und allein darin, dass ein anderer meine Plantage findet und aberntet.


    Doch die gleichen Risiken haben auch die Hanfbauern. Sie brauchen deshalb ein Sicherheitsdispositv (Kosten!), vertrauenswürdige (!) Mitarbeiter und Absatzkanäle. Da kommen ganz schön Kosten zusammen.


    Schade habe ich es nicht dieses Jahr probiert, denn die klimatischen Bedingungen waren und sind dieses Jahr hervorragend für eine tolle Ernte!

    Q1-Zahlen 2017

    @ Offline: Eventuell hier auch? *smile* *dirol*


    Wer hier noch interessiert ist:



    SMITHS FALLS, ON, Aug. 8, 2017 /CNW/ - Canopy Growth Corporation (TSX: WEED) ("Canopy Growth") will release its financial results for the first quarter fiscal 2018 ended June 30, 2017 on August 14, 2017.


    Following the release of its first quarter fiscal 2018 financial results, Canopy Growth will host a conference call and audio webcast with Bruce Linton, CEO and Tim Saunders, CFO at 8:30 AM Eastern Time the same day.


    Webcast Information
    A live audio webcast will be available at:
    http://event.on24.com/r.htm?e=…045655D0E0CBE2EBE71E7AFFD


    Calling Information
    Toll Free Dial-In Number: 1-888-231-8191
    International Dial-In Number (647) 427-7450
    Conference ID: 64439345


    Replay Information
    A replay of the call will be accessible by telephone until 11:59 PM ET on November 14, 2017.
    Toll Free Dial-in Number: 1-855-859-2056
    Replay Password: 64439345


    About Canopy Growth Corporation
    Canopy Growth is a world-leading diversified cannabis company, offering distinct brands and curated cannabis varieties in dried, oil and capsule forms. Through its wholly‑owned subsidiaries, Canopy Growth operates numerous state-of-the-art production facilities with over half a million square feet of GMP-certified indoor and greenhouse production capacity, all to an unparalleled level of quality assurance procedures and testing. Canopy Growth has established partnerships with leading sector names in Canada and abroad, with interests and operations spanning four continents. For more information visit www.canopygrowth.com.



    SOURCE Canopy Growth Corporation [Blocked Image: https://rt.newswire.ca/rt.gif?NewsItemId=C2922&Transmission_Id=201708080700CANADANWCANADAPR_C2922&DateId=20170808]


    For further information: Tyler Burns, Investor Relations, Tyler.burns@canopygrowth.com, 1-855-558-9333 ex 122; Jordan Sinclair, Director of Communications, Jordan@canopygrowth.com, 613-769-4196; Director: Bruce Linton, tmx@tweed.com, tmx@canopygrowth.com


    RELATED LINKS
    http://canopygrowth.com/

    Q1/2018

    CGC (WEED) Q1/2018



    Meinungen?


    Der Text mit Zahlen ist echt lang, drum s. Link unten:


    Anfang >


    Canopy Growth Corporation Reports First Quarter Fiscal 2018 Financial Results



    New presentation of per gram costs discloses separate cultivation to harvest, post-harvest and shipping and fulfillment costs, cost per gram to point of harvest was $0.76 per gram, the fourth consecutive quarter when the cost to point of harvest was less than $1 per gram


    Launch of Tweed Main Street ecommerce marketplace, offering consumer access to diverse range of products available from Company's multiple brands and CraftGrow partners, positions Company to lead backbone of future cannabis market


    Strong patient and healthcare practitioner response to encapsulated oil soft gel capsules validates investment required to bring to market; product demonstrates Company's commitment to medical patients and to lead the development of value added cannabis-based products


    SMITHS FALLS, ON, Aug. 14, 2017 /CNW/ - Canopy Growth Corporation (TSX: WEED) ("Canopy Growth" or "the Company") today released its consolidated financial results for the first quarter fiscal 2018, the period ended June 30, 2017. All financial information in this press release is reported in Canadian dollars, unless otherwise indicated.



    http://www.newswire.ca/news-re…al-results-640279773.html

    Es wäre jeweils von Vorteil, auch das Kürzel anzugeben oder die ISIN. Danke.



    Heutige News (WEED), ehemals TWEED:


    Canopy Growth firms up N.B. property acquisition


    2017-08-28 09:22 ET - News Release


    Mr. Bruce Linton reports


    CANOPY GROWTH SOLIDIFIES NEW BRUNSWICK EXPANSION STRATEGY


    Canopy Growth firms up N.B. property acquisition


    2017-08-28 09:22 ET - News Release



    Mr. Bruce Linton reports


    CANOPY GROWTH SOLIDIFIES NEW BRUNSWICK EXPANSION STRATEGY


    Canopy Growth Corp. has acquired Spot Therapeutics Inc., an ACMPR (access to cannabis for medical purposes regulations) applicant based in Fredericton, N.B. Additionally, through an affiliated entity, the Company has entered into a definitive agreement to complete the previously announced purchase of the industrial building and property where the Company's Fredericton-based production and distribution platform is being established. These strategic acquisitions solidify Canopy Growth's commitment to expand operations into New Brunswick with a large-scale indoor production facility both quickly, and cost efficiently.


    "New Brunswick has emerged as an excellent place to do business in the cannabis sector," said Bruce Linton, Chairman and CEO, Canopy Growth. "We will leverage our existing operational expertise and supplement what the team at Spot has already started so that we can get this facility up and running quickly, supporting local construction and trades to ensure we're making a meaningful contribution to the local economy."


    The facility will operate under the Tweed brand and support the Company's global operations with high quality, large scale cannabis production capabilities. The existing building and infrastructure is in excellent condition and includes almost 40,000 sq. ft. of dedicated production space. Once licensed, this initial footprint is anticipated to produce over 4,000 kg of dried cannabis annually. With the property appropriately zoned and suited for expansion to over 100,000 sq. ft., this location creates an ideal platform for future growth.


    On behalf of Bird Holdings Ltd., the current owner of the facility, its President J.W. Bud Bird said, "We are pleased by the sale of our building and impressed with the major expansion initiatives that the new owner, Canopy Growth, has planned for the property. It is great to have an investment of such a magnitude coming to Fredericton's Industrial Park, and it should prove to be an important long-term source of jobs and economic activity for all of central New Brunswick."


    Since originally announcing the intent to purchase the facility, Canopy Growth has been working diligently on amendments to the existing application to conform with the Company's standardized infrastructure layout and operating procedures. Engineering plans and drawings have already been completed and construction on the facility should begin in October 2017. The facility is anticipated to be ready for licensing and production before the end of 2017.


    Brian Neill, CEO of Spot commented, "We have been working for years to bring this new industry to Fredericton, and are proud to be joining forces with Canopy Growth and Tweed as we continue our journey towards an ACMPR license and the launch of a new cannabis platform in the Maritimes."


    Under the terms of the transaction, shareholders of Spot will receive up to $2,250,000 in total consideration, less adjustments for all liabilities of Spot as of the closing date and certain payments to be made by Spot between closing and the second tranche payment. At closing, and in satisfaction of the first tranche payment of $1,000,000, Canopy issued 111,669 common shares to the shareholders of Spot. The second tranche payment will be satisfied by the issuance of additional common shares, subject to completion of certain licensing and operational milestones. Closing of the acquisition of the industrial building and property in Fredericton is anticipated to close in early September.


    On August 25 th, 2017, Canopy Growth received conditional approval from the TSX for the issuance of common shares in connection with this transaction.


    Here's to Future (Maritime) Growth.


    About Tweed


    Tweed is a globally recognized marijuana production brand. It has built a large and loyal following by focusing on quality products and meaningful customer relationships. Tweed doesn't just sell marijuana, it facilitates a conversation about a product we've all heard about but haven't met intimately yet. It is approachable and friendly, yet reliable and trusted. As marijuana laws liberalize around the world, Tweed will expand its leading Canadian position around the globe. Learn more at http://www.tweed.com.


    About Canopy Growth Corporation


    Canopy Growth is a world-leading diversified cannabis company, offering diverse brands and curated cannabis strain varieties in dried and oil extract forms. Through its wholly-owned subsidiaries, Canopy Growth operates numerous state-of-the-art production facilities with over half a million square feet of indoor and greenhouse production capacity. Canopy Growth has established partnerships with leading sector names in Canada and abroad. For more information visit http://www.canopygrowth.com.


    We seek Safe Harbor.


    © 2017 Canjex Publishing Ltd. All rights reserved.


    Quelle. http://www.stockwatch.com/News…aspx?bid=Z-C:WEED-2499024

    Die Sache wird ja immer grösser, wenn man mal vom Kurs absieht. Der kann ja aber noch kommen, diesen Herbst.-


    Nesw:


    Canopy enters supply deal with Spanish pharma outfit


    2017-09-11 09:48 ET - News Release



    Mr. Bruce Linton reports


    CANOPY GROWTH CORPORATION ANNOUNCES STRATEGIC SPANISH PARTNERSHIP


    Canopy Growth Corp. and its wholly owned subsidiary Spektrum Cannabis GmbH have signed a supply licence agreement with Alcaliber SA, a leading player in the international pharmaceutical industry based in Spain. Alcaliber specializes in research and development, breeding and cultivation, and the extraction, purification and preparation of narcotic raw materials (NRM) and active pharmaceutical ingredients (API). This agreement is the first of its kind between a Canadian cannabis company and a significant, established international pharmaceutical player.


    "Entering this agreement with a large, well-recognized European partner like Alcaliber, with a proven background in controlled substances and an ability to produce plant-based medication solidifies our commitment to diversified production capabilities not just in Canada, but also new and emerging cannabis markets," said Bruce Linton, chairman and chief executive officer, Canopy Growth. "This agreement gives us additional resources to aggressively enter the European market where federally permitted by law, while we continue to work to establish our own complementary production footprint for cannabis cultivation, value-add oil extraction and softgel production in the European Union."


    Alcaliber has been granted a licence to cultivate, produce, manufacture, export/import and commercialize cannabis for medical and scientific purposes by the Spanish Agency of Medicinal Products and Medical Devices. As a result of this agreement, Canopy Growth and Spektrum will grant Alcaliber a licence to use certain strains and seeds to be grown and cultivated at Alcaliber's facilities for sale worldwide.


    "Alcaliber is really enthusiastic about pharmaceutical cannabis and our agreement with Canopy Growth and Spektrum is a perfect symbiosis," explained Jose Antonio de la Puente, CEO, Alcaliber. "There is a clear demand for pharmaceutical cannabis produced in accordance with pharmaceutical standards and the expertise we have developed manufacturing narcotic derivatives for over 40 years combined with Canopy Growth and Spektrum's cannabis experience will be a great step forward for the industry."


    As a proven global leader in pharmaceuticals with an established record of producing NRMs and APIs, as well as existing production infrastructure and distribution networks in place, Alcaliber's involvement has the potential to meaningfully expedite Spektrum's strategic expansion in the European market.


    Hacia el crecimiento


    About Canopy Growth Corp.


    Canopy Growth is a world-leading diversified cannabis company, offering distinct brands and curated cannabis varieties in dried, oil and capsule forms. Through its wholly owned subsidiaries, Canopy Growth operates numerous state-of-the-art production facilities with over half a million square feet of GMP-certified indoor and greenhouse production capacity, all to an unparalleled level of quality assurance procedures and testing. Canopy Growth has established partnerships with leading sector names in Canada and abroad, with interests and operations spanning four continents.


    We seek Safe Harbor.


    © 2017 Canjex Publishing Ltd. All rights reserved.

    Ich verfolge hier noch immer etwas die Berichte und sehe heute noch eine weitere Ausbreitung im Business,


    wie wohl diese Zahlen von Q2 kommen werden hier Ende November? Ich denke, ganz gut.



    SMITHS FALLS, ON, Sept. 13, 2017 /CNW/ - Canopy Growth Corporation (TSX:WEED) ("Canopy Growth" or the "Company") is pleased to announce that it has entered into a supply agreement with AusCann Group Holdings Ltd. ("AusCann"), whereby Canopy Growth will act as AusCann's exclusive supplier of medical cannabis for the Australian market, beginning with the transfer of a range of medicines for research and commercialization in Australia.


    The Australian market continues to present attractive growth opportunities for medical cannabis and through the Company's minority ownership stake and excellent working relationship with AusCann, it is in a prime position to realize this potential for its shareholders.


    "This agreement is a positive step in enabling Australian patients to have access to high quality cannabinoid medications," said Elaine Darby, Managing Director, AusCann. "I'm excited to move forward with this partnership, and continue to utilize the production scale of existing partners to accelerate our own sales function and market presence."


    As an emerging market, the size of this initial shipment is not expected to affect registered customer's ability to purchase product through Tweedmainstreet.com where consistent product availability has stabilized thanks to strong production from the Canopy-wide production platform.


    This agreement, which continues to allow Canopy Growth to pursue other Australian opportunities, follows a recent announcement issued September 11, 2017, in which the Company announced a strategic partnership with Alcaliber S.A. ("Alcaliber"), a leading pharmaceutical producer that last year exported 125 tonnes of alkaloids to 40 countries around the world, representing a 20% market share for Narcotic Raw Material (NRM).


    Whether Europe, South America, Australia, or at home, Canopy Growth is working hard to bring its recognized, high quality genetics to the world.


    Here's to Future Growth Down Under.

    Emil


    Ja, das denke ich auch. Hier noch von heute Morgen:


    News:


    SMITHS FALLS, ON and FREDERICTON, Sept. 15, 2017 /CNW/ - Canopy Growth Corporation (TSX: WEED) ("Canopy Growth" or the "Company") and the Province of New Brunswick today announced a significant milestone in the history of Canadian cannabis, whereby the Government of New Brunswick, through a newly created provincial authority and Canopy Growth, the largest licensed producer of regulated cannabis in the world, have entered into a supply Memorandum of Understanding (MOU) to guarantee a reliable and high-quality supply of cannabis products into New Brunswick's retail stores that will flow from a crown corporation newly formed by the province of New Brunswick.


    As one of the first MOUs between a licensed cannabis producer and a provincial body for cannabis supply for the retail environment, this is a concrete step towards the federally targeted date of July 2018 for legalization of recreational-use cannabis. Canopy Growth is excited, along with fellow producer Organigram, to be a part of this landmark moment, and commends the leadership shown by the Province of New Brunswick as it moves proactively to ensure its supply needs are met for the anticipated adult-use cannabis market.


    The two-year supply agreement, including 4,000,000 grams of cannabis and cannabis derivative products for the first year, is expected to have an estimated retail value of $40 million in its first year.


    "New Brunswick has led the country in its efforts to attract cannabis jobs and investment and Canopy Growth is proud to be utilizing local trades and to hire in New Brunswick for the site we are establishing in Fredericton," said Mark Zekulin, President, Canopy Growth. "Today we take the next step towards the future of cannabis in New Brunswick with a truly historic MOU. We are excited to bring high quality brands like Tweed, Leafs By Snoop, DNA Genetics, as well as a number of the best independent craft grow cannabis producers across Canada to the people of New Brunswick through this arrangement."


    Based on production capabilities across the Canopy-wide production platform, this agreement will not affect medical sales or our commitment to meeting the needs of Canadians who require cannabis for medical purposes.


    Staying true to its longstanding commitment to Corporate Social Responsibility, including partnerships with MADD Canada, the Canadian AIDS Society, Parent Action on Drugs, and a commitment to contribute funds from all online cannabis oil sales to education, Canopy Growth will proudly remit a monetary amount equal to two per cent of the gross value of all cannabis products sold to the government annually for social and/or educational programs.


    Here's to (Firsts, and) Future Growth.


    About Tweed
    Tweed is a globally recognized marijuana production brand. It has built a large and loyal following by focusing on quality products and meaningful customer relationships. Tweed doesn't just sell marijuana, it facilitates a conversation about a product we've all heard about but haven't met intimately yet. It is approachable and friendly, yet reliable and trusted. As marijuana laws liberalize around the world, Tweed will expand its leading Canadian position around the globe. Learn more at www.tweed.com.


    About Canopy Growth Corporation
    Canopy Growth is a world-leading diversified cannabis company, offering distinct brands and curated cannabis varieties in dried, oil and capsule forms. Through its wholly‑owned subsidiaries, Canopy Growth operates numerous state-of-the-art production facilities with over half a million square feet of GMP-certified indoor and greenhouse production capacity, all to an unparalleled level of quality assurance procedures and testing. Canopy Growth has established partnerships with leading sector names in Canada and abroad, with interests and operations spanning four continents. The Company is proudly dedicated to educating healthcare practitioners, providing consistent access to high quality cannabis products, conducting robust clinical research, and furthering the public's understanding of cannabis. For more information visit www.canopygrowth.com.


    Notice Regarding Forward Looking Statements
    This news release contains forward-looking statements. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects" or "does not expect", "is expected", "estimates", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Canopy Growth Corporation, Tweed Inc., Tweed Farms Inc., Mettrum Health Corp., or Bedrocan Canada Inc. to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Examples of such statements include future operational and production capacity, the impact of enhanced infrastructure and production capabilities, and forecasted available product selection. The forward-looking statements included in this news release are made as of the date of this news release and Canopy Growth Corp. does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.


    Neither the TSX Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Exchange) accepts responsibility for the adequacy or accuracy of this release.



    SOURCE Canopy Growth Corporation [Blocked Image: https://rt.newswire.ca/rt.gif?NewsItemId=C4914&Transmission_Id=201709150730CANADANWCANADAPR_C4914&DateId=20170915]


    For further information: Jordan Sinclair, Director of Communications, Jordan@canopygrowth.com, 613-769-4196, @CanopyGrowth; Investor Relations, Tyler Burns, Tyler.burns@canopygrowth.com, 855-558-9333 ex 122; Director: Bruce Linton, tmx@canopygrowth.com


    RELATED LINKS
    http://canopygrowth.com/

    External Content www.youtube.com
    Content embedded from external sources will not be displayed without your consent.
    Through the activation of external content, you agree that personal data may be transferred to third party platforms. We have provided more information on this in our privacy policy.

    9 Stocks to Benefit from the Canopy Growth and Constellation Brands Agreement


    5 hours 21 min ago


    Canopy Growth (WEED.TO) (TWMJF) has once again changed the landscape of the legal cannabis industry…


    Yesterday, the Wall Street Journal reported an investment by Constellation Brands (STZ: NYSE) into the Canadian licensed cannabis producer. Constellation will acquire 9.9% of Canopy Growth for $245 million (CAD) and has an option to increase the stake to 20%....


    https://technical420.com/canna…ellation-brands-agreement

    Lifestyle Delivery Systems Facility Begins Extraction and Formulation of Tested Material from Licensed Northern California Cultivators


    VANCOUVER, British Columbia, Oct. 31, 2017 /CNW/ -- Lifestyle Delivery Systems Inc. (CSE: LDS), (OTCQB: LDSYF) and (Frankfurt: LD6, WKN: A14XHT) ("LDS" or the "Company") announces that on October 26, 2017, the CSPA Group's extraction team from LDS Scientific began extraction and distillation of raw fresh frozen whole plant material for the purpose of conversion into medicinal cannabis products. An independent third party laboratory tested the whole plant material prior to processing. The results showed no trace amounts of pesticides, fungicides, mold or infestation. The LDS Scientific team is using fresh frozen whole plant material in order to preserve the complex array of cannabinoids, terpenes and flavonoids for inclusion into its medical cannabis products. The whole plant methodology may have additional benefits for patients if the entourage effect from combinations of plant chemicals described by some commentators results in enhanced benefits. There is no current clinical data developed in the U.S. to support these hypotheses, and the large majority of commentary is driven by anecdotal patient statements.




    Brad Eckenweiler CEO of LDS stated, "The extraction and distillation of whole plant material began last week and medicinal cannabis product formulations and distillate processing is beginning today. We will run sample products and begin taking orders this week and based on those orders we will schedule corresponding production runs. We are confident that the market is ready for our products and that customers will appreciate the added benefit of knowing that each and every product has been tested and is honestly represented in dosage and quality." The LDS Scientific team anticipates releasing sales figures by the end of November 2017.

    Selector hat am 31.10.2017 11:03 geschrieben:

    Quote

    Nun ja, der Kurs ist explodiert, + 19%. Freu... ob es hält?


    Zahlen sollten hier am 30.11.2017 rauskommen.


    http://www.stockhouse.com/news…nopy-growth-spikes-higher

    Mega. Yes. *i-m_so_happy*



    Selector & alle Fans hier: Canopy-Zahlen Q-2 werden am 14. November rauskommen. (Soeben gesehen).



    Canopy Growth Corporation to announce second quarter fiscal 2018 financial results


    News provided by


    Canopy Growth Corporation



    12:43 ET


    • -->

    SMITHS FALLS, ON, Oct. 31, 2017 /CNW/ - Canopy Growth Corporation (TSX: WEED) ("Canopy Growth") will release its financial results for the second quarter fiscal 2018 ended September 30, 2017 on November 14, 2017.


    Following the release of its second quarter fiscal 2018 financial results, Canopy Growth will host a conference call and audio webcast with Bruce Linton, CEO and Tim Saunders, CFO at 8:30 AM Eastern Time the same day.




    Webcast Information
    A live audio webcast will be available at: http://event.on24.com/r.htm?e=…B3AB2588D21AC8934F19F8520


    Calling Information
    Toll Free Dial-In Number: 1-888-231-8191
    International Dial-In Number (647) 427-7450
    Conference ID: 7498308


    Replay Information
    A replay of the call will be accessible by telephone until 11:59 PM ET on February 13, 2018.
    Toll Free Dial-in Number: 1-855-859-2056
    Replay Password: 7498308

    Emil


    Danke für die Terminangabe, hier kommen fast täglich gute Meldungen rüber:



    Canopy completes $245M share issuance to Constellation


    2017-11-02 09:05 ET - News Release



    Mr. Bruce Linton reports


    CANOPY GROWTH AND CONSTELLATION FINALIZE PREVIOUSLY ANNOUNCED STRATEGIC TRANSACTION


    Canopy Growth Corp. has completed the previously announced transaction that saw Constellation Brands strategically invest $245-million in Canopy Growth in exchange for 9.9-per-cent equity in the company following completion of the investment. As a result, the company has today issued 18,876,901 common shares in the company to an affiliate of Constellation in exchange for $244,990,084.25.


    In addition, the company also issued 18,876,901 warrants to the Constellation affiliate as part of this investment.


    Management looks forward to a long and productive collaborative relationship with Constellation.


    Here's to future growth.


    About Canopy Growth Corp.


    Canopy Growth is a world-leading diversified cannabis company, offering distinct brands and curated cannabis varieties in dried, oil and capsule forms. Through its wholly owned subsidiaries, Canopy Growth operates numerous state-of-the-art production facilities with over half a million square feet of GMP-certified indoor and greenhouse production capacity, all to an unparalleled level of quality assurance procedures and testing. Canopy Growth has established partnerships with leading sector names in Canada and abroad, with interests and operations spanning four continents.


    We seek Safe Harbor.


    © 2017 Canjex Publishing Ltd. All rights reserved.



    Gestern:


    Canopy Growth adds to strategic content & branding prowess by adding Ted Chung & Dave Bigioni to key roles


    News provided by


    Canopy Growth Corporation



    Nov 01, 2017, 07:00 ET



    Share this article


    SMITHS FALLS, ON, Nov. 1, 2017 /CNW/ - Canopy Growth Corporation (TSX: WEED) ("Canopy Growth" or the "Company") today announced that it has welcomed the founder of Stampede Management, Ted Chung, as a Strategic Advisor for Content Strategy to strengthen and leverage responsible brand opportunities for Tweed and other cannabis brands in the lead-up to the legal adult-use market in Canada.




    Mr. Chung has established himself as a thought leader and visionary in the cannabis media landscape as, among many notable accomplishments, a founder of MERRY JANE and an Executive Producer on the EMMY-Nominated television series Martha and Snoop's Potluck Dinner Party. Ted is also the longtime manager of cultural icon Snoop Dogg.


    Ted's joining builds upon the recent hiring of Dave Bigioni as the Chief Marketing Officer for all Canopy Growth brands. Mr. Bigioni joined the Company in August from an executive role at Molson Coors Brewing Company where he spent nine years in sales and marketing functions building one of Canada's iconic beer brands.


    Canopy Growth's leadership team has developed a collaborative working relationship with Mr. Chung highlighted by the partnership established with Leafs By Snoop in Canada in 2016.


    "I want to personally welcome Ted and Dave to the Canopy family," said Mark Zekulin, President, Canopy Growth. "In a competitive media landscape that rewards innovative approaches to responsible education and awareness, they have proven their ability to create stories and moments that resonate with people. I look forward to collaborating with them and bringing the exciting story about the people, products and vision of Tweed and all Canopy brands to life."


    "Canopy Growth and Tweed are progressive leaders across the board for our industry. I look forward to creating a content strategy that is thoughtful of where cannabis business is today and valuable to how cannabis culture is adopted by the mainstream within a year," commented Ted Chung.


    Here's to Future Growth.


    About Tweed
    Tweed is a globally recognized cannabis production brand. It has built a large and loyal following by focusing on quality products and meaningful customer relationships. Tweed doesn't just sell cannabis, it facilitates a conversation about a product we've all heard about but haven't met intimately yet. It is approachable and friendly, yet reliable and trusted. As cannabis laws liberalize around the world, Tweed will expand its leading Canadian position around the globe. Learn more at www.tweed.com.


    About Canopy Growth Corporation
    Canopy Growth is a world-leading diversified cannabis company, offering distinct brands and curated cannabis varieties in dried, oil and capsule forms. Through its wholly‑owned subsidiaries, Canopy Growth operates numerous state-of-the-art production facilities with over half a million square feet of GMP-certified indoor and greenhouse production capacity, all to an unparalleled level of quality assurance procedures and testing. Canopy Growth has established partnerships with leading sector names in Canada and abroad, with interests and operations spanning four continents. The Company is proudly dedicated to educating healthcare practitioners, providing consistent access to high quality cannabis products, conducting robust clinical research, and furthering the public's understanding of cannabis. For more information visit www.canopygrowth.com.

    Ja, schon wieder mega gute News von Canopy, bin mal gespannt auf den 14. November! *smile* *dirol*


    News provided byCanopy Growth Corporation


    07:00 ET



    Share this article


    SMITHS FALLS, ON, Nov. 7, 2017 /CNW/ - Canopy Growth Corporation (TSX: WEED) ("Canopy Growth" or "the Company") today announced that it has signed a definitive licensing agreement with Farm to Farma Inc. ("FTF") for FTF's innovative Trokie® lozenges. Under this licensing agreement, Canopy Growth will have the exclusive right to manufacture and distribute FTF's Trokie® lozenges through its subsidiaries in Canada, as permitted by federal regulations, and shall have a first right of offer for all other countries where federally lawful, and excluding the United States.



    [Blocked Image: https://mma.prnewswire.com/media/596502/Canopy_Growth_Corporation_Canopy_Growth_and_Farm_to_Farma_Form_D.jpg?w=950]


    Trokie is a cannabis lozenge developed to deliver a reliable and consistent dose of medical cannabis to its users (CNW Group/Canopy Growth...



    Developed by a Doctor of Pharmacy, Trokie® lozenges have been developed to deliver a consistent and repeatable dose of cannabis to its users. Trokie® features the most used polymer-based drug delivery system which allows for a zero-calorie product that avoids most common food allergies. There is no gluten, nuts, artificial flavours or colours, and the product meets vegan standards, utilizing many organic/natural ingredients.


    "We are very pleased to have entered into this license agreement for the Trokie® lozenges, a cannabis product that we believe has broad medical and legal adult access market opportunities," said Mark Zekulin, President, Canopy Growth Corporation. "We are confident value-added consumer products will drive higher margins and we will continue to look for thought leaders like Farm to Farma to expand our product offerings."


    Current ACMPR regulations allow for oil-based and dried cannabis products only, but Canopy Growth continues its licensing, and research and development programs to position itself for rapid diversification if and when the regulations allow for more varied formats in medical and adult access markets.


    "Signing this agreement with Canopy Growth is an exciting development for our company," said Shane Johnson, President, Farm to Farma Inc. "Combining Canopy's vision for the future of cannabis in consumer products and the deliberate investments they are making in capacity, with our unique line of products, has positioned us to increase our global footprint with the largest and most-respected cannabis company in the world."


    The Farm to Farma's Trokie® lozenge was designed specifically with the patient in mind. It is covered by an issued patent by FTF in the U.S., and is patent-pending in other jurisdictions including Canada. "By utilizing the oral mucosa for delivery, these lozenges have been developed to minimize first pass metabolism of cannabinoids by the liver, deliver a rapid onset of action, and optimize the bioavailability of every dose," said Dr. Kenton Crowley, the inventor of the Trokie®lozenge. Additional products such as transdermal patches and capsules are being added to the suite of products available under the Trokie® brand.


    Here's to Future Growth.


    ABOUT FARM TO FARMA, INC.
    Farm to Farma owns the intellectual property rights to Trokie®, a patented pharmaceutical lozenge that allows for rapid delivery of cannabis that is consistent, controllable and repeatable. Farm to Farma licenses Trokie® to legal manufacturers in various territories, including California, Nevada, Oregon, and Arizona. Farm to Farma is developing additional products under the Trokie® brand, and is evaluating the potential to add intellectual property related to other branded products to its portfolio.


    ABOUT CANOPY GROWTH CORPORATION
    Canopy Growth is a world-leading diversified cannabis company, offering distinct brands and curated cannabis varieties in dried, oil and capsule forms. Through its wholly‑owned subsidiaries, Canopy Growth operates numerous state-of-the-art production facilities with over half a million square feet of GMP-certified indoor and greenhouse production capacity, all to an unparalleled level of quality assurance procedures and testing. Canopy Growth has established partnerships with leading sector names in Canada and abroad, with interests and operations spanning four continents. The Company is proudly dedicated to educating healthcare practitioners, providing consistent access to high quality cannabis products, conducting robust clinical research, and furthering the public's understanding of cannabis. For more information visit www.canopygrowth.com.

    CGC (WEED)

    @ Emil und alle, die hier auf dem Weg sind:


    Da darf man auch gespannt sein, auf diesen Zahlen-Temin. Aber nicht nur dies sondern all die grandiosen Meldungen der letzten Tage und Wochen sind zukunftsweisend und Absolut wichtig für die weiteren Prognosen, die sich durch das Bisherige bereits im Vorfeld erahnen lassen.


    Da ist doch gleich noch was von heute: *smile* *dirol*


    Canopy, Delta 9 cheer Manitoba weed plan


    2017-11-08 06:53 ET - News Release


    Also News Release (C-NINE) Delta 9 Cannabis Inc


    Mr. Mark Zekulin of Canopy reports


    DELTA 9 AND CANOPY GROWTH APPLAUD MANITOBA CANNABIS PLAN


    Canopy Growth Corp. and Delta 9 Cannabis Inc. applaud the framework today announced by the Province of Manitoba regarding adult-use cannabis production, distribution and retail.


    The decision by the government of Manitoba to allow for private retail distribution of cannabis while ensuring that public safety and health concerns are the focal points of its cannabis policies is a strong and welcomed approach. As responsible existing cannabis businesses, Delta 9 and Canopy Growth plan to work collaboratively within the proposed Manitoba framework to bring locally produced products as well as the best variety from across the country to future cannabis consumers throughout the province.


    The companies submitted a collaborative expression of interest in July, 2017, outlining their proposed participation in the Manitoba market including production and distribution functions with both companies pursuing privately owned and operated retail.


    "As provinces continue to roll out distribution and retail strategies we are starting to gain a clearer understanding of our operational needs leading into next year," said Mark Zekulin, president, Canopy Growth.


    "Manitoba has signalled an openness to private retail operations, and as responsible private companies already meeting the strict regulations for the production and sale of medical cannabis across the country, we believe our track record positions us well to satisfy the government's objectives while meeting the needs of Manitoba consumers. We are proud to partner with a respected, responsible local Manitoba company in Delta 9 to bring our offering forward."


    While working together in Manitoba, Delta 9 has also entered into a distribution arrangement with Canopy Growth that will allow Delta 9 to expand its retail presence outside the province as Canopy pursues distribution deals similar to the agreement it entered with the Province of New Brunswick in September, 2017, to bring the highest-quality and best variety of products to consumers across the country.


    "As a cannabis producer headquartered in Winnipeg, our team is very pleased at the prospect of expanding our operations to include physical locations in addition to our existing e-commerce solution," said Delta 9 co-founder and chief executive officer John Arbuthnot.


    About Delta 9 Cannabis Inc.


    Delta 9's wholly owned subsidiary, Delta 9 Bio-Tech, is a licensed producer of medical marijuana pursuant to Health Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR) and operates an 80,000-square-foot, expandable, state-of-the-art production facility in Winnipeg, Man., Canada.


    We seek Safe Harbor.


    © 2017 Canjex Publishing Ltd. All rights reserved.

    Q-Zahlen am 14. November

    Kurze Frage, ich bin nicht sicher, werden die vorbörslich oder nachbörslich rausgebracht?


    Bin da auch seit einiger Zeit dabei und freue mich über die engagierte und gut aufgestellte Unternehmung.

    CGC (WEED)

    Lorenz hat am 08.11.2017 21:09 geschrieben:

    Quote

    Kurze Frage, ich bin nicht sicher, werden die vorbörslich oder nachbörslich rausgebracht?


    Bin da auch seit einiger Zeit dabei und freue mich über die engagierte und gut aufgestellte Unternehmung.

    Q-2 von CGC vorbörslich am14.November 2017